Cargando…
Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182393/ https://www.ncbi.nlm.nih.gov/pubmed/32333199 http://dx.doi.org/10.1007/s12253-020-00810-6 |
| _version_ | 1783526232746360832 |
|---|---|
| author | Tsiambas, Evangelos Papanikolaou, Vasileios Chrysovergis, Aristeidis Mastronikolis, Nicholas Ragos, Vasileios Kavantzas, Nikolaos Lazaris, Andreas C. Kyrodimos, Efthymios |
| author_facet | Tsiambas, Evangelos Papanikolaou, Vasileios Chrysovergis, Aristeidis Mastronikolis, Nicholas Ragos, Vasileios Kavantzas, Nikolaos Lazaris, Andreas C. Kyrodimos, Efthymios |
| author_sort | Tsiambas, Evangelos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7182393 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71823932020-04-27 Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19 Tsiambas, Evangelos Papanikolaou, Vasileios Chrysovergis, Aristeidis Mastronikolis, Nicholas Ragos, Vasileios Kavantzas, Nikolaos Lazaris, Andreas C. Kyrodimos, Efthymios Pathol Oncol Res Letter to the Editor Springer Netherlands 2020-04-24 /pmc/articles/PMC7182393/ /pubmed/32333199 http://dx.doi.org/10.1007/s12253-020-00810-6 Text en © Arányi Lajos Foundation 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Tsiambas, Evangelos Papanikolaou, Vasileios Chrysovergis, Aristeidis Mastronikolis, Nicholas Ragos, Vasileios Kavantzas, Nikolaos Lazaris, Andreas C. Kyrodimos, Efthymios Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19 |
| title | Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19 |
| title_full | Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19 |
| title_fullStr | Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19 |
| title_full_unstemmed | Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19 |
| title_short | Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19 |
| title_sort | coronavirus in hematologic malignancies: targeting molecules beyond the angiotensin-converting enzyme 2 (ace2) wall in covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182393/ https://www.ncbi.nlm.nih.gov/pubmed/32333199 http://dx.doi.org/10.1007/s12253-020-00810-6 |
| work_keys_str_mv | AT tsiambasevangelos coronavirusinhematologicmalignanciestargetingmoleculesbeyondtheangiotensinconvertingenzyme2ace2wallincovid19 AT papanikolaouvasileios coronavirusinhematologicmalignanciestargetingmoleculesbeyondtheangiotensinconvertingenzyme2ace2wallincovid19 AT chrysovergisaristeidis coronavirusinhematologicmalignanciestargetingmoleculesbeyondtheangiotensinconvertingenzyme2ace2wallincovid19 AT mastronikolisnicholas coronavirusinhematologicmalignanciestargetingmoleculesbeyondtheangiotensinconvertingenzyme2ace2wallincovid19 AT ragosvasileios coronavirusinhematologicmalignanciestargetingmoleculesbeyondtheangiotensinconvertingenzyme2ace2wallincovid19 AT kavantzasnikolaos coronavirusinhematologicmalignanciestargetingmoleculesbeyondtheangiotensinconvertingenzyme2ace2wallincovid19 AT lazarisandreasc coronavirusinhematologicmalignanciestargetingmoleculesbeyondtheangiotensinconvertingenzyme2ace2wallincovid19 AT kyrodimosefthymios coronavirusinhematologicmalignanciestargetingmoleculesbeyondtheangiotensinconvertingenzyme2ace2wallincovid19 |